Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Gross Profit (2018 - 2026)

Sunshine Biopharma filings provide 8 years of Gross Profit readings, the most recent being $3.0 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 2.08% to $3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.3 million, a 14.86% increase, with the full-year FY2025 number at $12.3 million, up 14.86% from a year prior.
  • Gross Profit hit $3.0 million in Q4 2025 for Sunshine Biopharma, down from $3.1 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $3.4 million in Q2 2025 to a low of $21538.0 in Q1 2021.
  • Median Gross Profit over the past 5 years was $2.0 million (2023), compared with a mean of $1.7 million.
  • Biggest five-year swings in Gross Profit: soared 6157.61% in 2022 and later fell 2.08% in 2025.
  • Sunshine Biopharma's Gross Profit stood at $23829.0 in 2021, then soared by 6157.61% to $1.5 million in 2022, then soared by 72.22% to $2.6 million in 2023, then grew by 20.44% to $3.1 million in 2024, then dropped by 2.08% to $3.0 million in 2025.
  • The last three reported values for Gross Profit were $3.0 million (Q4 2025), $3.1 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.